The Application of Proteomics in the Diagnosis and Treatment of Bronchial Asthma
Overview
Affiliations
Bronchial asthma is a common chronic inflammatory disease of the airways. Although its pathogenic mechanism remains unknown, it is influenced by both genetic and environmental factors. The emergence and application of proteomic technologies can help to facilitate analysis of the changes in transcription factors, inflammatory mediators, chemokines, cytokines, and cell apoptosis-and proliferation-related proteins in the pathological processes of asthma. Proteomic technologies can unearth prospects and theoretical bases for improved understanding of the biological mechanism of asthma and effective identification of diagnostic and therapeutic targets.
Omics approaches in asthma research: Challenges and opportunities.
Yue M, Tao S, Gaietto K, Chen W Chin Med J Pulm Crit Care Med. 2024; 2(1):1-9.
PMID: 39170962 PMC: 11332849. DOI: 10.1016/j.pccm.2024.02.002.
Evans W, Meslin E, Kai J, Qureshi N J Pers Med. 2024; 14(4).
PMID: 38673045 PMC: 11051552. DOI: 10.3390/jpm14040418.
Serum proteomics identifies novel diagnostic biomarkers for asthma in preschool children.
Ding H, Shi Z, Lin H, Sun Y, Zhang L, Liu F J Thorac Dis. 2024; 16(1):65-80.
PMID: 38410598 PMC: 10894366. DOI: 10.21037/jtd-23-974.
Asthma Phenotypes in the Era of Personalized Medicine.
Gonzalez-Uribe V, Romero-Tapia S, Castro-Rodriguez J J Clin Med. 2023; 12(19).
PMID: 37834850 PMC: 10573947. DOI: 10.3390/jcm12196207.
Next steps in precision approaches for asthma-proteomics and asthma endotypes.
Brasier A Ann Transl Med. 2022; 10(19):1047.
PMID: 36330385 PMC: 9622498. DOI: 10.21037/atm-22-4198.